Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Propofol + analgesic drug

Phase 3Small molecule

UUniversity Hospital, Brest

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q3 2026

Phase 3Recruiting

Sedation

NCT04341350

Clinical

Trials by Indication[1]

Sedation1 trial

Comparison of an Inhaled Sedation Strategy to an Intravenous Sedation Strategy in Intensive Care Unit Patients Treated With Invasive Mechanical Ventilation

Recruiting·UUniversity Hospital, Brest·Phase 3·NCT04341350·250 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Propofol + analgesic drug. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Propofol + analgesic drug compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Propofol + analgesic drug. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital, Brest company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: UUniversity Hospital, Brest

Related News